Skip to main content
OpenTrials
Completed

NCT Number: NCT05349422

Addressing Antihypertensive Medication Adherence Through EHR-enabled Teamlets in Primary Care

The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Blood Pressure Behavior Health Behavior Medication Adherence Patient Acceptance of Health Care Patient Compliance Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

NYU Langone Health

New York, 10016, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Individuals:

  • Age>18 years
  • Presence of Hypertension as defined by either:
  • Blood pressure ≥140/90
  • Hypertension diagnosis
  • Prescription for at least one antihypertensive medication
  • Outpatient clinic visit in the NYULH between 06/1/2022 and 12/31/2025

MAs, PCPs, LPNs, and RNs:

  • A clinician from an NYULH ambulatory practice location.

a. Eligible clinicians include physicians, medical assistants, licensed practical nurses, and registered nurses.

  • Adult patients during appointments with eligible clinicians
  • Age > 18 years

Exclusion criteria

  • Patients who decline to be observed.
  • The study team has no specific exclusion criteria for patients in chart review.

Treatment and study plan

Electronic Health Record (EHR) Enabled Teamlets

Behavioral

The intervention consist of four components: 1) patients with hypertension will be automatically screened for low medication adherence using linked EHR-pharmacy data at the time of a PCP encounter; 2) MAs will deliver a validated, rapid, survey of common causes of non-adherence; 3) MAs and/or RNs will address barriers to adherence tailored to survey response, including delivery of brief health coaching based on motivational interviewing; and 4) PCPs will address specific barriers to adherence based on survey response.

Primary outcomes

  1. Average Number of Days Covered (PDC) as a Measure of Medication Adherence

    Time frame: Month 12

    The percentage of days covered (PDC) is used to estimate medication adherence by looking at the percentage of days in which a person has access to the medication, over a given period of interest

Secondary outcomes

  1. Average Number of Days Covered (PDC) as a Measure of Medication Adherence

    Time frame: Month 18

    The percentage of days covered (PDC) is used to estimate medication adherence by looking at the percentage of days in which a person has access to the medication, over a given period of interest

  2. Mean Systolic Blood Pressure

    Time frame: Month 12

  3. Mean Systolic Blood Pressure

    Time frame: Month 18

  4. Mean Diastolic Blood Pressure

    Time frame: Month 12

  5. Mean Diastolic Blood Pressure

    Time frame: Month 18

Sponsors and collaborators

Lead sponsor

NYU Langone Health

Other

Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

Registry information

Important dates

Study start
2022
Primary completion
2024
Study completion
2025
First posted
Apr 27, 2022
Registry last updated
Jun 30, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.